SCHEMBL27744342

SCHEMBL27744342

CC(=O)O[C@@H]1CNCCN1c1ccc(Cl)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3E A5X5Y0 1/20 0.41
HTR3B O95264 1/20 0.41
ADRB1 P08588 1/20 0.41
HTR3A P46098 1/20 0.41
HTR3D Q70Z44 1/20 0.41
HTR3C Q8WXA8 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
LTA4H P09960 2/20 0.38
HTR2C P28335 9/20 0.37
HTR2A P28223 6/20 0.37
HTR2B P41595 5/20 0.37
ALDH1A1 P00352 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27744236 0.79 OPRM1 (0.38)
SCHEMBL1012668 0.76 MC4R (0.41) HTR3EHTR3BADRB1HTR3AHTR3D
SCHEMBL11076879 0.76 HTR3E (0.41) HTR3EHTR3BADRB1HTR3AHTR3D
SCHEMBL653537 0.76 MC4R (0.41) HTR3EHTR3BADRB1HTR3AHTR3D
SCHEMBL27613840 0.74 HTR3E (0.45) HTR3EHTR3BADRB1HTR3AHTR3D
SCHEMBL653307 0.73 HTR3A (0.50) HTR3EHTR3BADRB1HTR3AHTR3D
SCHEMBL335933 0.73 HTR3A (0.50) HTR3EHTR3BADRB1HTR3AHTR3D
SCHEMBL653028 0.73 HTR3A (0.50) HTR3EHTR3BADRB1HTR3AHTR3D
SCHEMBL656202 0.73 SLC6A2 (0.44) ADRB1ALDH1A1CYP2D6SLC6A2SLC6A4
SCHEMBL27810023 0.73 CHRM2 (0.38) CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101466728-A HCV inhibitors comprising beta amino acids and their uses NOVARTIS AG (CH) 2009-06-24 CN disclosed